logo BDSP

Base documentaire

  1. Clinical economics review : cost-effectiveness of treatment alternatives for gastro-oesophageal reflux disease.

    Article - En anglais

    Gastro-oesophageal reflux disease is a chronic recurring disorder, which is widespread, especially in Western societies.

    Faced with increasing health costs and finite resources, an increasingly important part of evaluating new treatments is economic appraisal.

    In this paper, we review critically the published economic studies of the cost-effectiveness of treatments for gastro-oesophageal reflux disease.

    Proton pump inhibitors are considered the best choice for the management of grades II-IV oesophagitis and are more cost-effective than H2-receptor antagonists because of their fast healing of oesophagitis, early relief of symptoms, and prevention of recurrent oesophagitis and development of complications.

    Mots-clés Pascal : Reflux gastrooesophagien, Chimiothérapie, Traitement, Oesophagite, Inhibiteur pompe proton, Antihistaminique, Récepteur histaminergique H2, Antagoniste, Article synthèse, Etude comparative, Analyse coût efficacité, Economie santé, Homme, Appareil digestif pathologie, Oesophage pathologie

    Mots-clés Pascal anglais : Gastroesophageal reflux, Chemotherapy, Treatment, Esophagitis, Proton pump inhibitor, Antihistaminic, H2 receptor, Antagonist, Review, Comparative study, Cost efficiency analysis, Health economy, Human, Digestive diseases, Esophageal disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0073297

    Code Inist : 002B02H. Création : 21/05/1997.